These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14524025)

  • 21. Pharmacological control of cardiac metabolism during acute heart failure.
    Vasků J; Bednarík B; Urbánek E
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():817-29. PubMed ID: 4806682
    [No Abstract]   [Full Text] [Related]  

  • 22. The relation between calcium ion transport and adenylate cyclase activity in myocardial sarcoplasmic-reticulum preparations.
    Gillibrand IM; Miall PA
    Biochem J; 1972 Jul; 128(3):109P. PubMed ID: 4634825
    [No Abstract]   [Full Text] [Related]  

  • 23. Myocardial metabolism in experimental cardiogenic shock.
    Cronin RF; Zsoter T; Hollenberg CH
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():95-100. PubMed ID: 4681505
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytokines mechanism of shenfu injection in treatment of cardiogenic shock in canine].
    Ke DZ; Chen QW; Li CL; Li GQ
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(21):2273-7. PubMed ID: 18309672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular effects of glucagon].
    Liakishev AA; Golikov AP
    Kardiologiia; 1972 Jul; 12(7):128-36. PubMed ID: 4364203
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Steroid and protease inhibition in refractory shock.
    Smith JA; Norman JN; Smith G
    Br J Surg; 1975 Feb; 62(2):164. PubMed ID: 1078781
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in the ultrastructure of the myocardium during the treatment of experimental cardiogenic shock with artificial left ventricle].
    Kniazeva GD; Rogov KA; Meluzov KL; Tolpekov VE
    Biull Eksp Biol Med; 1982 Mar; 93(3):16-9. PubMed ID: 7093472
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adenylate cyclase system and calcium transport in the cardiac muscle of normal rabbits and rabbits with allergic heart damage].
    Grozdova MD; Grigorovich IuA; Zubovskaia AM; Miroshnichenko VP; Sharlova IL
    Vopr Med Khim; 1980; 26(3):415-21. PubMed ID: 7456376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental cytotoxic necroses of the myocardium. Modeling and hemodynamic features of acute cardiocytotoxic shock. I].
    Gorev NN; Povzhitkov MM; Korol' SA; Sagach VF; Zaĭchenko AP
    Kardiologiia; 1973 Feb; 13(2):11-8. PubMed ID: 4775776
    [No Abstract]   [Full Text] [Related]  

  • 30. Production of a myocardial depressant factor in cardiogenic shock.
    Glenn TM; Lefer AM; Martin JB; Lovett WL; Morris JN; Wangensteen SL
    Am Heart J; 1971 Jul; 82(1):78-85. PubMed ID: 5581723
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
    Itoh T; Haruna M; Abe K
    Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary embolization with metallic mercury. A pathophysiological assessment of the lesion as a model of cardiogenic shock.
    Chandraratna PA; Oleksyn TW; Schenk EA; Cohen J
    Cardiovasc Res; 1973 Sep; 7(5):614-22. PubMed ID: 4753297
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of dopamine on experimental cardiogenic shock].
    Marchetti G; Merlo L; Noseda V
    Boll Soc Ital Cardiol; 1971; 16(10):615-9. PubMed ID: 5147986
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock.
    Ichinose F; Buys ES; Neilan TG; Furutani EM; Morgan JG; Jassal DS; Graveline AR; Searles RJ; Lim CC; Kaneki M; Picard MH; Scherrer-Crosbie M; Janssens S; Liao R; Bloch KD
    Circ Res; 2007 Jan; 100(1):130-9. PubMed ID: 17138944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic and oxyphoric aspects of septic and cardiogenic shock].
    Candiani A; Crimi G; Moschetta C; Romano R; Signore L
    Minerva Anestesiol; 1979; 45(7-8):536-56. PubMed ID: 548816
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relation between the degree of cardiodynamic disorders and the extent myocardium injury after cytotoxic exposure of the heart].
    Marchenko GI; Popovich LF; Buriakov IE
    Fiziol Zh (1978); 1983; 29(3):266-71. PubMed ID: 6873327
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model.
    Mi YF; Li XY; Tang LJ; Lu XC; Fu ZQ; Ye WH
    Chin Med J (Engl); 2009 Jun; 122(12):1423-8. PubMed ID: 19567165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Left ventricular function during acute ischemia.
    Kaspar RL; Bishop VS
    Am J Cardiol; 1974 Dec; 34(7):875-7. PubMed ID: 4432821
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.